Dan’s Biz Bookshelf: 'This Is Strategy: Make Better Plans'
The Chemical Connection: Reducing Defects in Circuit Board Production
It’s Only Common Sense: Trust Is All You Need
Endomag Renews Manufacturing Agreement with ITL Group
September 9, 2019 | ITL GroupEstimated reading time: 1 minute
Endomag has renewed a five-year manufacturing contract with ITL Group for on-going production of its commercially successful surgical guidance system, the Sentimag platform.
The Sentimag platform helps surgeons to mark, detect and accurately remove tumours or lymph nodes causing minimal damage to the breast tissue. The technology works like a metal detector, which when placed near the skin’s surface can detect Endomag’s magnetic seed (Magseed®) or magnetic lymph node tracer (Magtrace).
ITL Group successfully supported Endomag as it took the device from a proof of principle instrument to state-of-the-art medical technology. Endomag has won several awards for the design and production of the Sentimag® platform, including the Queen’s Award for Enterprise in Innovation in 2018.
"I am delighted to continue our relationship with the team at ITL. Their expertise in design, tooling and manufacture has helped fulfil our technology’s potential as we strive to make cancer care better for patients everywhere. I am looking forward to continuing to work together, as we grow to meet global demand for the Sentimag® system," said Eric Mayes, Endomag CEO.
ITL manufactures the platform in Britain for use all around the world. To this day, the Sentimag system is the world's most sensitive handheld magnetic probe, used in over 60,000 breast cancer procedures at over 400 hospitals in more than 30 countries.
"From humble beginnings as a spin-out from UCL, to now being one of ITL’s longest-standing customers, it has been an absolute pleasure to work alongside Eric and the team as they’ve grown from strength to strength. We’re delighted to secure another five years manufacturing with Endomag. They are a fantastic company to work alongside and we greatly value the opportunity to work with them longer term as they strive to improve the global standard of cancer care," ITL Managing Director Tom Cole said.
Share on:
Suggested Items
Zhen Ding Promotes Digital Transformation and Embraces AI Business Opportunities
06/06/2025 | Zhen Ding TechnologyOn May 27, 2025, General Manager Chen-Fu Chien of Zhen Ding Technology Group was invited to attend the "2025 Two Thousand Forum" held by The CommonWealth Magazine.
Orbel Corporation Integrates Schmoll Direct Imaging
06/04/2025 | Schmoll AmericaOrbel Corporation in Easton, PA, proudly becomes the first PCM facility in the U.S. equipped with Schmoll’s MDI Direct Imaging system. This installation empowers Orbel to support customers with greater precision and quality.
BAE Systems Unveils Comprehensive Line of M-Code GPS Receivers at Joint Navigation Conference
06/04/2025 | PRNewswireBAE Systems unveiled a diverse line of M-Code Global Positioning System (GPS) receiver solutions at the Joint Navigation Conference in Cincinnati this week, rounding out an extensive line of products that ensure U.S. warfighters have the most dependable GPS systems available across sea, land, and air.
Rehm Thermal Systems Mexico: Ten Years of Growth and Innovation in an Emerging Market
06/03/2025 | Rehm Thermal SystemsOver ten years ago, Luis A. Garcia began his success story at Rehm Thermal Systems. On May 15, 2013, he initially joined as a member of the Rehm USA team.
Indium Joins Virginia Tech Center for Power Electronics Systems Industry Consortium
06/03/2025 | Indium CorporationIndium Corporation®, a leading materials refiner, smelter, manufacturer, and supplier to the global electronics, semiconductor, thin-film, and thermal management markets, has joined Virginia Tech’s Center for Power Electronics Systems (CPES), an industry consortium that supports power electronics initiatives to reduce energy use while growing capability.